Literature DB >> 26088547

Polymyxin B Induced Generalized Hyperpigmentation in Neonates.

Sunil Gothwal1, Kailash Meena2, S D Sharma2.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26088547     DOI： 10.1007/s12098-015-1798-z

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  2 in total

1.  Diffuse cutaneous hyperpigmentation due to tigecycline or polymyxin B.

Authors:  Ryan C Knueppel; Joseph Rahimian
Journal:  Clin Infect Dis       Date:  2007-07-01       Impact factor: 9.079

Review 2.  Polymyxins revisited.

Authors:  David Landman; Claudiu Georgescu; Don Antonio Martin; John Quale
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132
  2 in total
  6 in total

1.  Polymyxin B-Induced Diffuse Cutaneous Hyperpigmentation.

Authors:  Sandeep Lahiry; Shouvik Choudhury; Ayan Mukherjee; Prajesh Kiran Bhunya; Moumita Bala
Journal:  J Clin Diagn Res       Date:  2017-02-01

2.  Proteomic Response Revealed Signaling Pathways Involving in the Mechanism of Polymyxin B-Induced Melanogenesis.

Authors:  Chuhan Zhang; Xiaofen Liu; Hailan Wu; Yu Wang; Yaxin Fan; Beining Guo; Xingchen Bian; Xin Li; Jing Zhang
Journal:  Microbiol Spectr       Date:  2022-04-04

Review 3.  Rescuing the Last-Line Polymyxins: Achievements and Challenges.

Authors:  Sue C Nang; Mohammad A K Azad; Tony Velkov; Qi Tony Zhou; Jian Li
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

Review 4.  Polymyxin B-induced skin hyperpigmentation: a rare case report and literature review.

Authors:  Guanhao Zheng; Li Cao; Zaiqian Che; Enqiang Mao; Erzhen Chen; Juan He
Journal:  BMC Pharmacol Toxicol       Date:  2018-07-04       Impact factor: 2.483

5.  The Difference Between Polymyxin B and Polymyxin E in Causing Skin Hyerpigmentation.

Authors:  Dongna Zou; Haitao Yu; Feifei Li
Journal:  Front Pharmacol       Date:  2021-04-16       Impact factor: 5.810

6.  Case Report: Therapeutic Drug Monitoring of Polymyxin B During Continuous Renal Replacement Therapy in Two Pediatric Patients: Do Not Underestimate Extracorporeal Clearance.

Authors:  Caifang Xu; Xiaofen Liu; Yun Cui; Xiaolan Huang; Yu Wang; Yaxin Fan; Hailan Wu; Xin Li; Beining Guo; Jing Zhang; Yucai Zhang
Journal:  Front Pharmacol       Date:  2022-03-24       Impact factor: 5.810
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.